Business UpdateJun 18, 2026, 08:02 AM
Bionano Genomics Sees 67% Growth in OGM Studies at ESHG 2026
AI Summary
Bionano Genomics announced a substantial increase in studies featuring its Optical Genome Mapping (OGM) technology at the 2026 European Society of Human Genetics (ESHG) conference, indicating expanding global adoption. The number of OGM studies grew by 67% to 35, with authorship from 17 countries across five global markets. Researchers highlighted OGM's ability to resolve complex genomic rearrangements and identify cryptic structural variants, particularly in rare and constitutional genetic disorders, hematologic malignancies, and hereditary cancer.
Key Highlights
- 35 studies featured Optical Genome Mapping (OGM) at ESHG 2026, a 67% increase from 21 studies in 2025.
- Authorship for OGM studies spanned 17 countries in 2026, up from 12 in 2025, across five global markets.
- Rare and constitutional genetic disorders represented roughly half of the OGM studies.
- Europe contributed the most studies overall, with Brazil being the single largest national contributor.
- Studies demonstrated OGM's ability to resolve complex genomic rearrangements and identify cryptic structural variants.
- OGM was featured both standalone and combined with other genomic analysis methods like sequencing.
Price Impact
More from BNGO